Newsfeeds - Spark Newswire

2 minute read

Lantheus Announces Presentation Featuring PYLARIFY (Piflufolastat F18) At 2022 ASCO GU Meeting On Feb. 17

Today, 8:53 PM

Lantheus Holdings, Inc. (the "Company") (NASDAQ:LNTH), an established leader and fully integrated provider committed to innovative imaging diagnostics, targeted therapeutics and artificial intelligence

LNTH

2 minute read

Lantheus Collaborates With The Prostate Cancer Clinical Trial Consortium (PCCTC) To ‘Advance AI-Enabled Imaging Biomarkers in Prostate Cancer’

By Bill Haddad

Today, 8:53 PM

Lantheus Holdings, Inc. (NASDAQ:LNTH) (Lantheus) announced that its subsidiary, EXINI Diagnostics AB (EXINI), has entered into a collaboration with the Prostate Cancer Clinical Trials Consortium (PCCTC) to advance

LNTH

2 minute read

News

Lantheus Announces PYLARIFY AI Is Now Available

By Benzinga Newsdesk

Today, 8:53 PM

Lantheus Holdings, Inc. (NASDAQ:LNTH) (Lantheus), an established leader and fully integrated provider committed to innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to find,

LNTH

2 minute read

Earnings

How Good Are Lantheus Holdings’s Earnings? | Return On Capital Employed

By Benzinga Insights

Today, 8:53 PM

According to Benzinga Pro data, during Q3, Lantheus Holdings (NASDAQ:LNTH) posted sales of $102.07 million. Earnings were up 46.5%, but Lantheus Holdings still reported an overall loss of $14.33 million.

LNTH

32 minute read

Earnings Scheduled For November 4, 2021

By Benzinga Insights

Today, 8:53 PM

Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion.

AAOI

7 minute read

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline

By Shanthi Rexaline

Today, 8:53 PM

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected.

ADPT

2 minute read

FDA
News

Lantheus Announces Addition Of PSMA PET Imaging Agent To National Comprehensive Cancer Network (NCCN) Guidelines For Prostate Cancer

By Benzinga Newsdesk

Today, 8:53 PM

LNTH

2 minute read

Earnings

Return on Capital Employed Overview: Lantheus Holdings

By Benzinga Insights

Today, 8:53 PM

After pulling data from Benzinga Pro it seems like during Q2, Lantheus Holdings (NASDAQ:LNTH) brought in sales totaling $101.06 million. However, earnings decreased 7559.89%, resulting in a loss of $26.78 million.

LNTH

1 minute read

SVB Leerink Maintains Outperform on Lantheus Holdings, Raises Price Target to $34

By Benzinga Newsdesk

Today, 8:53 PM

SVB Leerink analyst Richard Newitter maintains Lantheus Holdings (NASDAQ:LNTH) with a Outperform and raises the price target from $31 to $34.

LNTH

5 minute read

The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer’s Conference, IPOs and More

By Shanthi Rexaline

Today, 8:53 PM

Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start to the pharma reporting season.

ABBV